Hampton Creek Press (print and distribution provided by Simon & Schuster) Announces Behind a Closed Door, the Latest Novel by Writer J.D. Barker
April 17, 2024 13:51 ET
|
Hampton Creek Press
The long-awaited thriller from New York Times bestselling author J.D. Barker is available for preorder now and will be released on May 13, 2024.
Ress Life Investments A/S: Ress Life Investments A/S publishes portfolio composition for Q1 2024
April 17, 2024 11:01 ET
|
Ress Life Investments A/S
Ress Life Investments A/SNybrogade 12DK-1203 CopenhagenDenmarkCVR nr. 33593163resslifeinvestments.com To: Nasdaq CopenhagenDate: 17 April 2024 Corporate Announcement 15/2024 Ress Life...
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to Participate in April Investor Conferences
Global Travel Insurance Market Forecast to 2028: Increasing Demand for Comprehensive Coverage Options
March 13, 2024 11:45 ET
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Travel Insurance Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis" report has been added to ...
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to present posters on the importance of Neuropilin-2 in immune regulation at the Keystone Symposia on Myeloid Cell Diversity.
Ress Life Investments A/S: Ress Life Investments A/S publishes portfolio composition for Q4 2023
January 16, 2024 11:30 ET
|
Ress Life Investments A/S
Ress Life Investments A/SNybrogade 12DK-1203 CopenhagenDenmarkCVR nr. 33593163resslifeinvestments.comTo: Nasdaq CopenhagenDate: 16 January 2024 Corporate Announcement 03/2024 Ress...
PIMCO Names Sung-Hee Suh as Global General Counsel
November 30, 2023 10:00 ET
|
PIMCO Account Management
NEWPORT BEACH, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- PIMCO, a global leader in active fixed income with expertise across public and private markets, has named Sung-Hee Suh as Global General...
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
November 13, 2023 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
Cell Culture Media Market revenue to hit USD 54 Billion by 2035, says Research Nester
November 13, 2023 06:30 ET
|
Research Nester
New York , Nov. 13, 2023 (GLOBE NEWSWIRE) -- The global cell culture media market size is slated to expand at 19% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 54...
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
November 09, 2023 16:00 ET
|
aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...